Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Cadiz – page 14

220 clinical trials in Cadiz, Spain across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Cadiz at a glance
220
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

220 trials in Cadiz

Open in trial search

Pancreatitis acute+1

Not recruiting

Study on Simvastatin for Preventing Recurrent Pancreatitis in Patients

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Lactose Monohydrate
  • Sponsor:Hospital General Universitario Dr. Balmis

Cardiomyopathy+1

Not recruiting

Study on the Effectiveness of Autologous Bone Marrow Cells for Patients with Dilated Cardiomyopathy and Heart Failure

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Autologous Bone Marrow-Derived Adult Mononuclear Cells, Not Expanded
  • Sponsor:Red Andaluza De Diseno Y Traslacion De Terapias Avanzadas Fundacion Publica Andaluza Progreso Y Salud

Bladder cancer

Not recruiting

Study of Atezolizumab with BCG Treatment for Patients with High-Risk Non-Muscle Invasive Bladder Cancer Who Have Not Previously Received BCG

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Atezolizumab
  • Sponsor:Unicancer

Obesity

Not recruiting

Study of Setmelanotide for Patients with Obesity Due to Specific Genetic Variants

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Setmelanotide
  • Sponsor:Rhythm Pharmaceuticals Inc.

Study on Diarrhea Discontinuations in Early-stage HER2+ Breast Cancer Patients Treated with Neratinib, Loperamide, and Colesevelam

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Neratinib
  • Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer De Mama

Study of Rucaparib and Nivolumab for Maintenance Treatment in Patients with Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer After Chemotherapy

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:pharmaand GmbH

Multiple sclerosis+2

Not recruiting

Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Relapsing Multiple Sclerosis

Registered drug
Countries:SpainSpain
  • Participants:18–64 years
  • Substances:Methylprednisolone
  • Sponsor:F. Hoffmann-La Roche AG

Study on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide
  • Sponsor:Janssen Cilag International

Study on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:F. Hoffmann-La Roche AG

Study of Chemotherapy and Nivolumab Before and After Surgery for Patients with Non-Small Cell Lung Cancer in the Upper Lung Area

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:Fundacion GECP

Study of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Janssen Cilag International

Migraine+1

Not recruiting

Study of Eptinezumab as Add-on Treatment for Prevention of Migraine in Adults with Both Migraine and Medication Overuse Headache

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Eptinezumab
  • Sponsor:H. Lundbeck A/S

Other cities in Spain

The busiest research cities in the country

All 210 cities in Spain

Clinical research in Cadiz

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on bladder cancer treatments, including studies of mitomycin C delivery and immunotherapy approaches. Research extends to pancreatic adenocarcinoma and triple-negative breast cancer, evaluating new therapeutic combinations.

  • Non-muscle invasive bladder cancer treatments
  • Neoadjuvant therapy for pancreatic cancer
  • Immunotherapy combinations

Studies are exploring both localized and advanced disease states with emphasis on improving survival rates.

02 Immunology and Allergies

Groundbreaking research in allergic conditions and autoimmune disorders, including studies on hidradenitis suppurativa and innovative immunotherapy approaches for allergic rhinitis.

  • Allergen-specific immunotherapy
  • Inflammatory skin conditions
  • Respiratory allergies

Trials aim to evaluate novel therapeutic agents and treatment protocols for chronic conditions.

03 Transplant Medicine

Studies focusing on improving outcomes in kidney transplantation, particularly addressing delayed graft function through innovative therapeutic approaches.

  • Prevention of graft rejection
  • Post-transplant complications
  • Novel immunosuppressive strategies

Research aims to enhance transplant success rates and reduce post-operative complications.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.